Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.79 USD | -0.62% | +1.10% | +13.81% |
Mar. 14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
Mar. 13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.81% | 380M | |
-2.68% | 85.68B | |
+4.08% | 41.4B | |
-25.35% | 28.22B | |
+54.31% | 24.64B | |
-4.52% | 16.98B | |
-42.09% | 13.29B | |
-17.77% | 11.66B | |
-12.10% | 11.65B | |
+0.75% | 8.18B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q3 Revenue $39.5M, vs. Street Est of $36.3M